Oncotide® is a proprietary, human albumin-based formulation designed to deliver chemotherapy directly to the liver, minimizing systemic exposure and reducing side effects. It is indicated for the treatment of patients with unresectable hepatocellular carcinoma (HCC) in combination with fluoropyrimidine-based chemotherapy.